期刊文献+

弥漫大B细胞淋巴瘤中survivin的表达及其与细胞增殖和凋亡的关系 被引量:1

Gene expression of survivin and its relationships with cell apoptosis and proliferation in diffuse large B-cell lymphoma
下载PDF
导出
摘要 目的:检测survivin在弥漫大B细胞淋巴瘤(DLBCL)中的表达,及其与细胞增殖和凋亡的相关性。方法:收集77例DLBCL和15例反应性增生淋巴组织,运用免疫组织化学EnVision法检测survivin和细胞增殖相关抗原Ki-67的表达,采用TdT介导的dUTP缺口末端标记技术(TUNEL)检测细胞凋亡指数。结果:Survivin在DLBCL中表达的阳性率为74%(57/77),在反应性增生淋巴组织中表达的阳性率为13%(2/15),二者差异有显著性(P<0.05)。Survivin表达与淋巴瘤增殖指数、凋亡指数呈明显正相关(r值分别为0.741,0.325,P<0.01)。结论:Survivin基因在DLBCL中表达上调,可能通过促进细胞增殖对DLBCL的发生发展起重要作用。 Objective To investigate gene expression of survivin and its relationships with cell apoptosis and proliferation in diffuse large B-cell lymphoma (DLBCL) tissues. Methods Immunohistochemistry methods and Tdt-mediated dUTP nick end labeling (TUNEL) methods was used to detect the expression of surviving, Ki-67 and cell apoptosis in DLBCL tissues (n=77) and reactive hyperplasia lymphoid tissues (n=lS), respectively. Results The expression of survivin was significantly lower in reactive hyperplasia lymphoid tissues (13%, 2/15) than that in DLBCL tissues (74%, 57/77)(P 〈 0.05), being positively correlated with proliferation index and apoptosis index (r=0.741, 0.325, P 〈 0.01 ). Conclusion Survivin is highly expressed in DLBCL tissues, which may contribute to the progression of DLBCL by regulating cell proliferation.
出处 《实用医学杂志》 CAS 2007年第18期2856-2858,共3页 The Journal of Practical Medicine
关键词 淋巴瘤 大细胞 弥漫型 SURVIVIN 凋亡 增殖 Lymphoma, large-cell, diffuse Survivin Apoptosis Proliferation
  • 相关文献

参考文献11

二级参考文献21

  • 1[1]Adida C, Crotty PL, Mograth S,et al.Developmentally regulated expression of the cancer anti-apoptosis gene survivin in human and mouse differation[J]. Am J Pathol,1998,152(1):43-49. 被引量:1
  • 2[2]Ambrosini G, Adida C,Altieri DC. A novel anti-apoptosis gene, Survivin, expression in cancer and lymphoma[J]. Nat Med,1997,3(8):917-921. 被引量:1
  • 3[3]Tamm I, Wang Y, Sausville E, et al. IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas(CD95), Bax, caspases,and anticancer drugs[J]. Cancer Res,1998,58(23):5315-5320. 被引量:1
  • 4[4]Lo Muzio L, Staibano S, Pannone G, et al. Expression of the apoptosis inhibitor Survivin in aggressive squamous cell carcinoma[J]. Exp Mol Pathol, 2001,70(3):249-254. 被引量:1
  • 5[5]O'connor DS,Schechner JS,Adida C,et al.Control of apoptosis during angiogenisis by Survivin express in endothelial cell[J]. Am J Pathol,2000, 156(2):393-398. 被引量:1
  • 6[6]Korkolopoulou P, Oates J, Kittas C, et al. P53, C-myc P62 and proliferating cell nuclear antigen(PCNA) expression in non-Hodgkin's lymphomas[J]. J Clin Pathol, 1994,47(1):9-14. 被引量:1
  • 7[7]Leoncini L, Del Vecchio MT, Spina D,et al. Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern[J]. Int J Cancer,1995,61(6):826-831. 被引量:1
  • 8[8]Suzuki A, Ito T, Kawano H, et al.Survivin initiates procaspase 3/p21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death[J]. Oncogene,2000,19(10):1346-1353. 被引量:1
  • 9LACASSE E C,BAIRD S,KORNELUK R G,et al.The inhibitors of apoptosis(IAPs)and their emerging role in cancer[J].Oncogene,1998,17(25):3247-3259. 被引量:1
  • 10DARIO C,ALTIERI L,CARLO M.Survivin apoptosis:an interloper between cell death and cell proliferation in cancer[J].Lab Invest,1999,79(11):1327-1333. 被引量:1

共引文献10

同被引文献8

  • 1Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma[J]. N Engl J Med,2002,346(4):235-242. 被引量:1
  • 2Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B- cell lymphoma: a randomised controlled trial by the MabThera International Trim (MINT) Group[J]. Lancet oncol,2006,7 (5) :379-391. 被引量:1
  • 3The International Non-Hodgkin's Lymphoma Prognostic Factors Project.A Predictive Model for Aggressive Non-Hodgkin's Lymphoma [J]. N Engl J Med, 1993,329(14) : 987-994. 被引量:1
  • 4Cheson BD, Homing S J, Coiffier B, et al. Report of an international workshop to standardize response criteria for nonHodgkin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 1999,17(4) : 1244. 被引量:1
  • 5Adida C, Crotty PL, McGrath J,et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation [J]. Am J Pathol, 1998,152 (1) :43-49. 被引量:1
  • 6Islam A, Kageyama H, Takada N, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma [ J ]. Oncogene, 2000, 19 ( 5 ) : 617-623. 被引量:1
  • 7Paydas S, Ergin M, Seydaoglu G, et al. Prognostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature [J]. Leuk Res,2009, 33(12) : 1627-1635. 被引量:1
  • 8李军,刘敏,丛春燕,原荣,魏曙亚,侯蓉,王一羽.非霍奇金淋巴瘤组织中突变型p53、bcl-2、Ki-67及survivin蛋白表达及临床意义[J].现代肿瘤医学,2009,17(4):729-731. 被引量:2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部